Health and Healthcare
BioHealth Business Daily (ACUR, AMLN, BIIB, ELN, CADX, CYCC, HGSI, MIPI, PRAN, RNN, SQNM)
Published:
Last Updated:
Today’s version of the BioHealth Business Daily is again full of stocks on the move with news, and some not on news. Array BioPharma, Inc. (NASDAQ: ARRY), BioDelivery Services International Inc. (NASDAQ: BDSI), Biogen Idec Inc. (NASDAQ: BIIB), Biosante Pharmaceuticals, Inc. (NASDAQ: BPAX), CytRx Corporation (NASDAQ: CYTR), Human Genome Sciences, Inc. (NASDAQ: HGSI), Neuralstem, Inc. (AMEX: CUR), and Prana Biotechnology Ltd. (NASDAQ: PRAN) are all on the move.
Array BioPharma, Inc. (NASDAQ: ARRY) is the biggest winner so far on a $467 million drug pact that was an alternative to a merger. Shares have held up rather well and the stock is up 35% at $4.09 on almost 16 million shares. Shares hit $4.25 today and the 52-week high is $4.65.
BioDelivery Services International Inc. (NASDAQ: BDSI) is one of the worst performers in the BioHealth space due to its raising $10 million in a registered direct offering from institutional investors. Shares are down over 14% at $3.61 on over 2 million shares of stock. The market cap is a mere $76 million and the average volume here is only about 90,000 shares.
Biogen Idec Inc. (NASDAQ: BIIB) is one of the few situations where a Carl Icahn movement needs to actually work out. The stock is down today, but just marginally, after the TYSABRI drug maker for MS said its profit fell on charges despite Tysabri sales having risen. Shares are down 1.9% at $53.74 and we have not quite yet seen the 2.6 million shares hit on an average day.
Biosante Pharmaceuticals, Inc. (NASDAQ: BPAX) is trading up again today. Yesterday’s news was that it will present and separately participate in a cancer immunotherapy panel discussion at the World Vaccine Congress. Shares are up 5.8% at $2.00 on what is already triple volume after 1.8+ million shares have traded hands.
CytRx Corporation (NASDAQ: CYTR) is up after its Bafetinib received a positive opinion from the Committee for Orphan Medicinal Products in the European Union indication for treatment of chronic myeloid leukemia or CML. Shares are up 9.7% at $1.13 on over 6 million shares mid-afternoon, which is already about 8-times normal volume if they closed the market now. Its market cap is $123 million and the 52-week trading range is $0.35 to $1.72.
Human Genome Sciences, Inc. (NASDAQ: HGSI) is in trouble, and frankly it is lucky the fallout is not worse. The company’s GlaxoSmithKline-partner study of topline 76-week results of its Phase III trial of Benlysta in Systemic Lupus Erythematosus actually failed to meet a secondary endpoint. The primary endpoint is still met, but this is a disappointment. Shares are down 6% at $29.60 on more than 22 million shares. The 52-week range is $1.16 to $34.49 and the average volume is a more 3.1 million shares.
Neuralstem, Inc. (AMEX: CUR) is up on what may be no fixed news other than outside commentary. Shares are up over 20% at $2.75 and the trading volume is very high with well over 2 million shares having traded hands.
Prana Biotechnology Ltd. (NASDAQ: PRAN) played more profit taking after yesterday’s large run up followed by profit taking. Shares closed up 78% at $2.41 yesterday but had been as high as $3.35 after showing some Alzheimer’s Disease effects reversed in some study presentations. The stock is down another 15% at $2.05 today on over 2.3 million shares.
You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.
JON C. OGG
The Average American Has No Idea How Much Money You Can Make Today (Sponsor)
The last few years made people forget how much banks and CD’s can pay. Meanwhile, interest rates have spiked and many can afford to pay you much more, but most are keeping yields low and hoping you won’t notice.
But there is good news. To win qualified customers, some accounts are paying almost 10x the national average! That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 3.80% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.
Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.
Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 4.00% with a Checking & Savings Account from Sofi. Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.